Skip to content

FP7

ADVANCE

Accelerated Development of Vaccine benefit-risk Collaboration in Europe

Programme
Seventh Framework Programme
Started
Ends
Duration
66 months
Total cost
EUR 11,344,501
EU contribution
EUR 4,999,811
Participants
27 from 11 countries
Topic
FP7_IMI-JU-07-2012-01
Grant agreement
115557

Coordinated by P95 (BEBelgium).

Consortium

EU contribution per participant as the open data of CORDIS states it; for a participant with linked third parties it may include their share, and a participant whose amount the data does not hold or cannot make consistent shows Not stated. A participant who left the project is not listed; see the history below.

Members of the consortium, coordinator first
OrganisationCountryRoleEU contributionRecognised by
P95BEBelgiumCoordinatorEUR 544,004PIC (1.00)
Glaxosmithkline Biologicals SABEBelgiumParticipantNot statedPIC (1.00)
SciensanoBEBelgiumParticipantEUR 240,777known name (0.95)
Novartis Pharma AGCHSwitzerlandParticipantNot statedPIC (1.00)
Takeda Pharmaceuticals International AGCHSwitzerlandParticipantNot statedPIC (1.00)
Universitat BaselCHSwitzerlandParticipantEUR 381,074known name (0.95)
Aarhus UniversitetshospitalDKDenmarkParticipantEUR 155,764known name (0.95)
Statens Serum InstitutDKDenmarkParticipantEUR 241,230known name (0.95)
Agencia Espanola de Medicamentos y Productos SanitariosESSpainParticipantEUR 125,452known name (0.95)
Fundacio Institut Universitari Pera la Recerca a L'Atencio Primaria de Salut Jordi Gol i GurinaESSpainParticipantEUR 37,790PIC (1.00)
Synapse Research Management Partners SLESSpainParticipantEUR 757,235PIC (1.00)
Tampereen Korkeakoulusaatio SrFIFinlandParticipantEUR 161,195known name (0.95)
Sanofi Pasteur SAFRFranceParticipantNot statedPIC (1.00)
London School of Hygiene and Tropical Medicine Royal CharterGBUnited KingdomParticipantEUR 89,533PIC (1.00)
Medicines and Healthcare products Regulatory AgencyGBUnited KingdomParticipantEUR 36,654known name (0.95)
The Royal College of General PractitionersGBUnited KingdomParticipantEUR 166,275PIC (1.00)
University of SurreyGBUnited KingdomParticipantEUR 462,600known name (0.95)
Agenzia di Tutela della Salute della ValpadanaITItalyParticipantEUR 105,299PIC (1.00)
Agenzia Regionale di SanitaITItalyParticipantEUR 33,290PIC (1.00)
Societa Servizi Telematici SRLITItalyParticipantEUR 109,683PIC (1.00)
Erasmus Universitair Medisch Centrum RotterdamNLNetherlandsParticipantEUR 546,123PIC (1.00)
Janssen Vaccines & Prevention BVNLNetherlandsParticipantNot statedPIC (1.00)
Rijksinstituut Voor Volksgezondheid en MilieuNLNetherlandsParticipantEUR 224,664known name (0.95)
The European Medicines AgencyNLNetherlandsParticipantEUR 219,246PIC (1.00)
European Centre for Disease Prevention and ControlSESwedenParticipantEUR 220,221known name (0.95)
Karolinska InstitutetSESwedenParticipantEUR 59,528known name (0.95)
Merck Sharp & Dohme CorpUSUnited StatesParticipantNot statedPIC (1.00)

Changes of the consortium

First seen on with 27 participants from 11 countries.

A snapshot of each project's members is taken once a month; a change is recorded when a snapshot differs from the one before. A project with no change listed has had the same members since it was first observed.

Project page on CORDIS (opens in new tab)

Where this comes from

EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.

Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.